Cleared Special

K153359 - BardPort®, SlimPort®, and X-Port® Implanted Ports (FDA 510(k) Clearance)

May 2016
Decision
182d
Days
Class 2
Risk

K153359 is an FDA 510(k) clearance for the BardPort®, SlimPort®, and X-Port® Implanted Ports. This device is classified as a Port & Catheter, Implanted, Subcutaneous, Intravascular (Class II - Special Controls, product code LJT).

Submitted by C.R. Bard, Inc. (Salt Lake Ciy,, US). The FDA issued a Cleared decision on May 20, 2016, 182 days after receiving the submission on November 20, 2015.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5965.

Submission Details

510(k) Number K153359 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 20, 2015
Decision Date May 20, 2016
Days to Decision 182 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code LJT — Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5965

Similar Devices — LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

Vaccess™ CT Low-Profile Power-Injectable Implantable Port
K252478 · Bard Access Systems, Inc. · Sep 2025
PowerPort™ isp Implantable Port
K251253 · Bard Access Systems, Inc. · Jun 2025
PowerPort™ ClearVUE™ Slim Implantable Ports and PowerPort™ ClearVUE™ Slim Implantable Ports
K242328 · Bard Access Systems, Inc. · Oct 2024
PowerPort™ ClearVUE™ Slim ECG Enabled Implantable Port
K232737 · Bard Peripheral Vascular, Inc. · Dec 2023